What are the most effective strategies for enabling the translation of novel discoveries from the laboratory to market to enhance health? Is there a systematic process-driven approach to efficiently and effectively develop early stage technologies into commercially viable products? This session’s panelists bring perspectives from the corporate (J&J), non-profit (BioAccel), and federal government (NIH) arenas to explore strategies to accelerate the development of academic innovations into evidence-based healthcare. Is there a one-size-fits-all model or just common denominators? Do we reward disclosure and fast failure? What lessons are transportable? How can best practices be disseminated and encouraged globally?

Key Takeaways:

  • Define success for a systems approach to identify, define, justify, and prioritize early-stage academic discovery and technology development
  • Examine how academic entrepreneurism and new company survival can be “de-risked” by combining the right resources, many of which exist in the academic environment
  • Discuss why knowledge of failed attempts and outcomes—rarely transparent—can be more valuable than reciting stories of success

Ability Level: All

Session ID: 2499

myBIO Chatter
Educational Topics